GENTAUR Belgium BVBA BE0473327336 Voortstraat 49, 1910 Kampenhout BELGIUM Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc,Logistics 547 Yurok Circle, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, [email protected]

Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, Gentaur another in time delivery

Pubmed ID: 31796953
Publication Date: 2019/12/04

Metabolic effects of a prolonged, very-high-dose dietary fructose challenge in healthy subjects.


Increased fructose intake has been associated with metabolic consequences such as impaired hepatic lipid metabolism and development of nonalcoholic fatty liver disease (NAFLD).

The aim of this study was to investigate the role of fructose in glucose and lipid metabolism in the liver, heart, skeletal muscle, and adipose tissue.

Ten healthy subjects (age: 28 ± 19 y; BMI: 22.2 ± 0.7 kg/m2) underwent comprehensive metabolic phenotyping prior to and 8 wk following a high-fructose diet (150 g daily). Eleven patients with NAFLD (age: 39.4 ± 3.95 y; BMI: 28.4 ± 1.25) were characterized as "positive controls." Insulin sensitivity was analyzed by a 2-step hyperinsulinemic euglycemic clamp, and postprandial interorgan crosstalk of lipid and glucose metabolism was evaluated, by determining postprandial hepatic and intra-myocellular lipid and glycogen accumulation, employing magnetic resonance spectroscopy (MRS) at 7 T. Myocardial lipid content and myocardial function were assessed by 1H MRS imaging and MRI at 3 T.

High fructose intake resulted in lower intake of other dietary sugars and did not increase total daily energy intake. Ectopic lipid deposition and postprandial glycogen storage in the liver and skeletal muscle were not altered. Postprandial changes in hepatic lipids were measured [Δhepatocellular lipid (HCL)_healthy_baseline: -15.9 ± 10.7 compared with ± ΔHCL_healthy_follow-up: -6.9 ± 4.6; P = 0.17] and hepatic glycogen (Δglycogen_baseline: 64.4 ± 14.1 compared with Δglycogen_follow-up: 51.1 ± 9.8; P = 0.42). Myocardial function and myocardial mass remained stable. As expected, impaired hepatic glycogen storage and increased ectopic lipid storage in the liver and skeletal muscle were observed in insulin-resistant patients with NAFLD.

Ingestion of a high dose of fructose for 8 wk was not associated with relevant metabolic consequences in the presence of a stable energy intake, slightly lower body weight, and potentially incomplete absorption of the orally administered fructose load. This indicated that young, metabolically healthy subjects can at least temporarily compensate for increased fructose intake. This trial was registered at www.clinicaltrials.gov as NCT02075164.
Authors: Smajis Sabina , Gajdošík Martin , Pfleger Lorenz , Traussnigg Stefan , Kienbacher Christian , Halilbasic Emina , Ranzenberger-Haider Tamara , Stangl Anna , Beiglböck Hannes , Wolf Peter , Lamp Tanja , Hofer Astrid , Gastaldelli Amalia , Barbierri Chiara , Luger Anton , Trattnig Siegfried , Kautzky-Willer Alexandra , Krššák Martin , Trauner Michael , Krebs Michael ,

Reference:

  1. ncbi.nlm.nih.gov. [Last access 2019/12/04].

Related products :

Catalog number Product name Quantity
29-558 KHK is a ketohexokinase that catalyzes conversion of fructose to fructose-1-phosphate. The product of this gene is the first enzyme with a specialized pathway that catabolizes dietary fructose.KHK enc 0.05 mg
orb82779 Human TNF alpha Variant protein The clinical use of the potent antitumor activity of TNF-alpha has been limited by the proinflammatory side effects including fever, dose-limiting hypotension, hepatoto 1 mg
K2-BFU2-2RH HALO-Tox HT, GFS: EPO (high dose), Population: BFU-E 2, Rat 2 Plate Kits
K2-BFU2-2CH HALO-Tox HT, GFS: EPO (high dose), Population: BFU-E 2, Dog 2 Plate Kits
K2-BFU2-4RH HALO-Tox HT, GFS: EPO (high dose), Population: BFU-E 2, Rat 4 Plate Kits